Your browser doesn't support javascript.
Effect of Psychological-Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients.
Kong, Xiangyu; Kong, Fanyang; Zheng, Kailian; Tang, Min; Chen, Yi; Zhou, Jiahuan; Li, Yi; Diao, Le; Wu, Shouxin; Jiao, Piqi; Su, Tong; Dong, Yuchao.
  • Kong X; Huoshenshan Hospital, Wuhan, China.
  • Kong F; Department of Gastroenterology, Shanghai Changhai Hospital, Shanghai, China.
  • Zheng K; Huoshenshan Hospital, Wuhan, China.
  • Tang M; Huoshenshan Hospital, Wuhan, China.
  • Chen Y; Huoshenshan Hospital, Wuhan, China.
  • Zhou J; Shanghai Zhangjiang Institute of Medical Innovation, Shanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
  • Li Y; Huoshenshan Hospital, Wuhan, China.
  • Diao L; Shanghai Zhangjiang Institute of Medical Innovation, Shanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
  • Wu S; Shanghai Zhangjiang Institute of Medical Innovation, Shanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
  • Jiao P; Huoshenshan Hospital, Wuhan, China.
  • Su T; College of Psychology, Naval Medical University, Shanghai, China.
  • Dong Y; Huoshenshan Hospital, Wuhan, China.
Front Psychiatry ; 11: 586355, 2020.
Article in English | MEDLINE | ID: covidwho-972122
ABSTRACT
The COVID-19 epidemic has caused increasing public panic and mental health stress. In this study, we explore the prevalence and factors linked to anxiety and depression in hospitalized patients with COVID-19. A total of 144 patients diagnosed with COVID-19 underwent depression and anxiety assessment by using the Hospital Anxiety and Depression Scale (HADS). Social support level was also evaluated by the Perceived Social Support Scale (PSSS) at admission. Results showed that gender, age, oxygen saturation, and social support were associated with anxiety for COVID-19 patients. In addition, age, family infection with SARS-CoV-2, and social support were the risk factors associated with depression. Moreover, we designed a psychological-behavioral intervention (PBI) program that included psychological support and breathing exercises, and explored its effects on patients with COVID-19. Of the 144 participants, 26 patients with both anxiety and depression symptoms (cutoff score of ≥8 on HADS-A and HADS-D) were randomly assigned to the intervention group and the control group at a 11 ratio. After 10-day treatment, the HADS scores of depression and anxiety were significantly reduced in the intervention group, and PSSS scores were also significantly improved. However, no significant differences in HADS and PSSS scores between pre- and post-treatment were found in the control group. Our findings indicate that mental concern and appropriate intervention are essential parts of clinical care for COVID-19 patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Front Psychiatry Year: 2020 Document Type: Article Affiliation country: Fpsyt.2020.586355

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Front Psychiatry Year: 2020 Document Type: Article Affiliation country: Fpsyt.2020.586355